Global formulation development outsourcing market is projected to accomplish an extraordinary growth in the forecast period, 2022-2026 with an impressive CAGR. The market growth can be attributed to growing popularity of the outsourcing market for the formulation development. Moreover, biopharmaceutical companies with their joint ventures with academia, Contact Research Organizations (CRO) and biotechnology startup companies is further supporting the growth of the global formulation development outsourcing market in the upcoming five years. Rapidly increasing pharmaceutical companies, and bio-pharmaceutical players are further supporting the growth of the global market in the next five years. The recent event of COVID-19 proved to be one of the major factors influencing the growth of the market. To combat the virus spread, and its infectious outcomes, multiple biotechnological companies were focused over the research and development of the vaccines, drugs, and immunity booster drugs that are effective over the virus. Similar research and development of the pharmaceutical drugs for the diseases like cancer, etc. are further supporting the growth of the global formulation development outsourcing market in the forecast years until 2026.

The global formulation development outsourcing market is segmented by services, dosage form, application, end user, regional distribution, and competitional landscape. Based on services, the market is further differentiated into pre-formulation services and formulation optimization. Pre-formulation services are again differentiated into discovery & preclinical services and analytical services whereas formulation optimization is differentiated again into phase I, phase II, phase III, phase IV. Formulation optimization service is anticipated to register larger revenue shares of the market and assert its dominance over the market on the account of various services that are available for the same. Solubility and pH profile studies, drug/excipient compatibility studies, preservative screening, selection, and testing, manufacture of lab-scale and feasibility batches, and feasibility studies all account for the various services under formulation optimization. Pre-formulation services is expected to have significant growth in upcoming five years on the account of increasing research and development and rapidly multiplying biotechnology and bio-pharmaceutical companies in the recent years.  

Holding the major shares of the global formulation development outsourcing market are Charles River Laboratories International, Inc., Catalent Inc., Quotient Bioresearch Ltd., Aizant Drug Research Solutions Private Limited, Laboratory Corporation of America Holdings, Syngene International Ltd, Irisys LLC, Intertek Group plc, Piramal Pharma Limited, Emergent BioSolutions Inc., Lonza Group AG, Dr. Reddy's Laboratories Ltd, Thermo Fischer Scientific, Inc. (Patheon), PCI Pharma Services, Hermes Pharma, among others. Market players are actively involved in the research and technological development in the medical device and testing kit developments. The advanced technology has made it possible for the healthcare industry to provide excellent healthcare services through Formulation Development Outsourcing. Further advancement would aid the market value and brand establishment in the future five years. New market players may focus on the research and development to provide options that satisfies the consumer demand as well as benefits the market players in building their brand value. Other competitive strategies include mergers & acquisitions and new product developments.

Years considered for this report:

Historical Years: 2016 – 2019

Base Year: 2020

Estimated Year: 2021

Forecast Period: 2022 – 2026

Objective of the Study:

  • To analyze the historical growth of the market size of global formulation development outsourcing market from 2016 to 2019.
  • To estimate and forecast the market size of global formulation development outsourcing market from 2020 to 2026 and growth rate until 2026. 
  • To classify and forecast global formulation development outsourcing market based on services, dosage form, application, end user, competitional landscape, and regional distribution.
  • To identify dominant region or segment in the global formulation development outsourcing market.
  • To identify drivers and challenges for global formulation development outsourcing market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global formulation development outsourcing market.
  • To identify and analyze the profile of leading players operating in global formulation development outsourcing market.
  • To identify key sustainable strategies adopted by market players in global formulation development outsourcing market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and distributors across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.

TechSci Research calculated the market size of global formulation development outsourcing market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Manufacturers, end users, and other stakeholders
  • Distributers and suppliers of products and other stakeholders
  • Organizations, forums, and alliances related to formulation development outsourcing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global formulation development outsourcing market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Formulation Development Outsourcing Market, By Services:
    • Pre-Formulation Services
      • Discovery & Preclinical Services
      • Analytical Services
    • Formulation Optimization
      • Phase I
      • Phase II
      • Phase III
      • Phase IV
  • Global Formulation Development Outsourcing Market, By Dosage Form:
    • Oral
    • Topical
    • Intravenous
    • Others
  • Global Formulation Development Outsourcing Market, By Application:
    • Oncology
    • Genetic Disorders
    • Neurology
    • Infectious Diseases
    • Respiratory
    • Cardiovascular
    • Others
  • Global Formulation Development Outsourcing Market, By End User:
    • Pharmaceutical & Biopharmaceutical Companies
    • Governments
    • Academic & Research Institutions
    • Others
  • Global Formulation Development Outsourcing Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global formulation development outsourcing market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global Formulation Development Outsourcing Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Formulation Development Outsourcing Market

4.    Voice of Customer

5.    Executive Summary

6.    Global Formulation Development Outsourcing Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Services (Pre-Formulation Services v/s Formulation Optimization)

6.2.1.1.         By Pre-Formulation Services (Discovery & Preclinical Services v/s Analytical Services)

6.2.1.2.         By Formulation Optimization (Phase I, Phase II, Phase III, Phase IV)

6.2.2.     By Dosage Form (Oral, Topical, Intravenous, Others)

6.2.3.     By Application (Oncology, Genetic Disorders, Neurology, Infectious Diseases, Respiratory, Cardiovascular, Others)

6.2.4.     By End User (Pharmaceutical & Biopharmaceutical Companies, Governments, Academic & Research Institutions, Others)

6.2.5.     By Region

6.2.6.     By Company (2020)

6.3.  Product Market Map

7.    North America Formulation Development Outsourcing Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Services (Pre-Formulation Services v/s Formulation Optimization)

7.2.1.1.         By Pre-Formulation Services (Discovery & Preclinical Services v/s Analytical Services)

7.2.1.2.         By Formulation Optimization (Phase I, Phase II, Phase III, Phase IV)

7.2.2.     By Dosage Form (Oral, Topical, Intravenous, Others)

7.2.3.     By Application (Oncology, Genetic Disorders, Neurology, Infectious Diseases, Respiratory, Cardiovascular, Others)

7.2.4.     By End User (Pharmaceutical & Biopharmaceutical Companies, Governments, Academic & Research Institutions, Others)

7.2.5.     By Country

7.3.  North America: Country Analysis

7.3.1.     United States Formulation Development Outsourcing Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Services

7.3.1.2.2.             By Dosage Form

7.3.1.2.3.             By Application

7.3.1.2.4.             By End User

7.3.2.     Mexico Formulation Development Outsourcing Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Services

7.3.2.2.2.             By Dosage Form

7.3.2.2.3.             By Application

7.3.2.2.4.             By End User

7.3.3.     Canada Formulation Development Outsourcing Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Services

7.3.3.2.2.             By Dosage Form

7.3.3.2.3.             By Application

7.3.3.2.4.             By End User

8.    Europe Formulation Development Outsourcing Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Services (Pre-Formulation Services v/s Formulation Optimization)

8.2.1.1.         By Pre-Formulation Services (Discovery & Preclinical Services v/s Analytical Services)

8.2.1.2.         By Formulation Optimization (Phase I, Phase II, Phase III, Phase IV)

8.2.2.     By Dosage Form (Oral, Topical, Intravenous, Others)

8.2.3.     By Application (Oncology, Genetic Disorders, Neurology, Infectious Diseases, Respiratory, Cardiovascular, Others)

8.2.4.     By End User (Pharmaceutical & Biopharmaceutical Companies, Governments, Academic & Research Institutions, Others)

8.2.5.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Formulation Development Outsourcing Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Services

8.3.1.2.2.             By Dosage Form

8.3.1.2.3.             By Application

8.3.1.2.4.             By End User

8.3.2.     United Kingdom Formulation Development Outsourcing Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Services

8.3.2.2.2.             By Dosage Form

8.3.2.2.3.             By Application

8.3.2.2.4.             By End User

8.3.3.     Italy Formulation Development Outsourcing Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Services

8.3.3.2.2.             By Dosage Form

8.3.3.2.3.             By Application

8.3.3.2.4.             By End User

8.3.4.     Germany Formulation Development Outsourcing Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Services

8.3.4.2.2.             By Dosage Form

8.3.4.2.3.             By Application

8.3.4.2.4.             By End User

8.3.5.     Spain Formulation Development Outsourcing Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Services

8.3.5.2.2.             By Dosage Form

8.3.5.2.3.             By Application

8.3.5.2.4.             By End User

9.    Asia-Pacific Formulation Development Outsourcing Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Services (Pre-Formulation Services v/s Formulation Optimization)

9.2.1.1.         By Pre-Formulation Services (Discovery & Preclinical Services v/s Analytical Services)

9.2.1.2.         By Formulation Optimization (Phase I, Phase II, Phase III, Phase IV)

9.2.2.     By Dosage Form (Oral, Topical, Intravenous, Others)

9.2.3.     By Application (Oncology, Genetic Disorders, Neurology, Infectious Diseases, Respiratory, Cardiovascular, Others)

9.2.4.     By End User (Pharmaceutical & Biopharmaceutical Companies, Governments, Academic & Research Institutions, Others)

9.2.5.     By Country

9.3.  Asia-Pacific: Country Analysis

9.3.1.     China Formulation Development Outsourcing Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Services

9.3.1.2.2.             By Dosage Form

9.3.1.2.3.             By Application

9.3.1.2.4.             By End User

9.3.2.     India Formulation Development Outsourcing Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Services

9.3.2.2.2.             By Dosage Form

9.3.2.2.3.             By Application

9.3.2.2.4.             By End User

9.3.3.     Japan Formulation Development Outsourcing Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Services

9.3.3.2.2.             By Dosage Form

9.3.3.2.3.             By Application

9.3.3.2.4.             By End User

9.3.4.     South Korea Formulation Development Outsourcing Market Outlook

9.3.4.1.         Market Size & Forecast

9.3.4.1.1.             By Value

9.3.4.2.         Market Share & Forecast

9.3.4.2.1.             By Services

9.3.4.2.2.             By Dosage Form

9.3.4.2.3.             By Application

9.3.4.2.4.             By End User

9.3.5.     Australia Formulation Development Outsourcing Market Outlook

9.3.5.1.         Market Size & Forecast

9.3.5.1.1.             By Value

9.3.5.2.         Market Share & Forecast

9.3.5.2.1.             By Services

9.3.5.2.2.             By Dosage Form

9.3.5.2.3.             By Application

9.3.5.2.4.             By End User

10.  South America Formulation Development Outsourcing Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Services (Pre-Formulation Services v/s Formulation Optimization)

10.2.1.1.      By Pre-Formulation Services (Discovery & Preclinical Services v/s Analytical Services)

10.2.1.2.      By Formulation Optimization (Phase I, Phase II, Phase III, Phase IV)

10.2.2.  By Dosage Form (Oral, Topical, Intravenous, Others)

10.2.3.  By Application (Oncology, Genetic Disorders, Neurology, Infectious Diseases, Respiratory, Cardiovascular, Others)

10.2.4.  By End User (Pharmaceutical & Biopharmaceutical Companies, Governments, Academic & Research Institutions, Others)

10.2.5.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Formulation Development Outsourcing Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Services

10.3.1.2.2.           By Dosage Form

10.3.1.2.3.           By Application

10.3.1.2.4.           By End User

10.3.2.  Argentina Formulation Development Outsourcing Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Services

10.3.2.2.2.           By Dosage Form

10.3.2.2.3.           By Application

10.3.2.2.4.           By End User

10.3.3.  Colombia Formulation Development Outsourcing Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Services

10.3.3.2.2.           By Dosage Form

10.3.3.2.3.           By Application

10.3.3.2.4.           By End User

11.  Middle East and Africa Formulation Development Outsourcing Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Services (Pre-Formulation Services v/s Formulation Optimization)

11.2.1.1.      By Pre-Formulation Services (Discovery & Preclinical Services v/s Analytical Services)

11.2.1.2.      By Formulation Optimization (Phase I, Phase II, Phase III, Phase IV)

11.2.2.  By Dosage Form (Oral, Topical, Intravenous, Others)

11.2.3.  By Application (Oncology, Genetic Disorders, Neurology, Infectious Diseases, Respiratory, Cardiovascular, Others)

11.2.4.  By End User (Pharmaceutical & Biopharmaceutical Companies, Governments, Academic & Research Institutions, Others)

11.2.5.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Formulation Development Outsourcing Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Services

11.3.1.2.2.           By Dosage Form

11.3.1.2.3.           By Application

11.3.1.2.4.           By End User

11.3.2.  UAE Formulation Development Outsourcing Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Services

11.3.2.2.2.           By Dosage Form

11.3.2.2.3.           By Application

11.3.2.2.4.           By End User

11.3.3.  Saudi Arabia Formulation Development Outsourcing Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Services

11.3.3.2.2.           By Dosage Form

11.3.3.2.3.           By Application

11.3.3.2.4.           By End User

11.3.4.  Kuwait Formulation Development Outsourcing Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Services

11.3.4.2.2.           By Dosage Form

11.3.4.2.3.           By Application

11.3.4.2.4.           By End User

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape (Inclusive of SWOT Analysis)

14.1.              Charles River Laboratories International, Inc.

14.2.              Catalent Inc.

14.3.              Quotient Bioresearch Ltd.

14.4.              Aizant Drug Research Solutions Private Limited

14.5.              Laboratory Corporation of America Holdings

14.6.              Syngene International Ltd

14.7.              Irisys LLC

14.8.              Intertek Group plc

14.9.              Piramal Pharma Limited

14.10.            Emergent BioSolutions Inc.

14.11.            Lonza Group AG

14.12.            Dr. Reddy's Laboratories Ltd

14.13.            Thermo Fischer Scientific, Inc. (Patheon)

14.14.            PCI Pharma Services

14.15.            Hermes Pharma

15.  Strategic Recommendations

16.  About Us & Disclaimer